Arquivamento definitivo - Art. 33 da LPI
#11.1.1
03/18/2025
RPI 2828
Application data
Number
112023012484Type
Filing
Publication
PCT
US2021064350 The application was abandoned: examination was not requested within the 36 months following the 12/20/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 03/18/2025. We update with every new RPI gazette, published weekly.
Applicants
CHEMOCENTRYX, INC.
US
Inventors
P. S. (pessoa física)
US
P. B. (pessoa física)
US
IPC Classification
Priority claims
US
63/128,397 · 12/21/2020
Abstract
TRATAMENTO DE GLOMERULOPATIA POR C3 USANDO UM INIBIDOR DE C5A São proporcionados métodos de tratamento de certas populações de pacientes humanos sofrendo de ou suscetíveis a glomerulopatia por C3, compreendendo administrar ao humano uma quantidade eficaz de um antagonista de C5aR.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
03/18/2025
RPI 2828
#11.1
12/31/2024
RPI 2817
#1.3
07/18/2023
RPI 2741
#1.1
07/04/2023
RPI 2739
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.